Skip to main content
Immune Deficiency Foundation logo

Merck

We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

merck.com 908-740-4000
Scientist wearing glasses uses dropper to perform work in lab

PI diagnosis sparks PhD candidate’s neuroimmunology research interest

February 09, 2024
Read article
Black and white photograph taken of Charles Drew.

Pioneer of Plasma in honor of Black History Month

February 06, 2024
Read article
Woman with zebra stripes on face 2

Adulting with PI support group leader specializes in trauma

January 31, 2024
Read article
Complement deficiencies thumbnail image

Complement deficiencies

January 30, 2024
Watch video
Y-shaped antibody molecule.

Decoding antibody deficiency diagnoses

January 25, 2024
Read article
Print Material Fallback

Strategic Plan 2024-2026

January 25, 2024
View PDF
Doctor with older patient

Bill of Rights for individuals with primary immunodeficiencies

January 25, 2024
View PDF
Genetics

Addressing accessibility of gene and cell therapies

January 24, 2024
View PDF
A mom, dad, and children hug and smile

Parents push Medicaid to cover four-year-old’s thymus tissue implant

January 23, 2024
Read article
Subscribe to
IDF logo
Immune Deficiency Foundation
7550 Teague Road, Suite 220
Hanover, Maryland 21076

P: 410-321-6647

Seal Platinum logo
Charity Navigator logo
NHC logo
Nord logo

The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.​

We foster a community that is connected, engaged, and empowered through advocacy, education, and research.

Donate

© 2026 Immune Deficiency Foundation | Immune Deficiency Foundation is a 501(c)(3) organization (EIN: 52-1214782)